Rookus M - Search Results

1

Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study.

Antoniou AC, Rookus M, Andrieu N, Brohet R, Chang-Claude J, Peock S, Cook M, Evans DG, Eeles R; EMBRACE; Nogues C, Faivre L, Gesta P; GENEPSO; van Leeuwen FE, Ausems MG, Osorio A; GEO-HEBON; Caldes T, Simard J, Lubinski J, Gerdes AM, Olah E, Fürhauser C, Olsson H, Arver B, Radice P, Easton DF, Goldgar DE. Antoniou AC, et al. Among authors: rookus m. Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):601-10. doi: 10.1158/1055-9965.EPI-08-0546. Epub 2009 Feb 3. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19190154 Free article.

2

Differences in breast cancer risk factors to neu (c-erbB-2) protein overexpression of the breast tumor.

Treurniet HF, Rookus MA, Peterse HL, Hart AA, van Leeuwen FE. Treurniet HF, et al. Among authors: rookus ma. Cancer Res. 1992 Apr 15;52(8):2344-5. Cancer Res. 1992. PMID: 1348449

3

[Does breast feeding protect against breast cancer? An epidemiological study].

Haring MH, Rookus MA, van Leeuwen FE. Haring MH, et al. Among authors: rookus ma. Ned Tijdschr Geneeskd. 1992 Apr 11;136(15):743-7. Ned Tijdschr Geneeskd. 1992. PMID: 1560867 Dutch.

4

Agreement between oral contraceptive users and prescribers: implications for case-control studies.

van Leeuwen FE, van Duijn CM, Camps MH, Kempers BA, Mentjens MF, Mulder HB, Schouten EG, Zwijsen RM, Rookus MA. van Leeuwen FE, et al. Among authors: rookus ma. Contraception. 1992 May;45(5):399-408. doi: 10.1016/0010-7824(92)90154-l. Contraception. 1992. PMID: 1623713 Free article.

5

The role of exogenous hormones in the epidemiology of breast, ovarian and endometrial cancer.

van Leeuwen FE, Rookus MA. van Leeuwen FE, et al. Among authors: rookus ma. Eur J Cancer Clin Oncol. 1989 Dec;25(12):1961-72. doi: 10.1016/0277-5379(89)90378-7. Eur J Cancer Clin Oncol. 1989. PMID: 2698811 Review.

6

Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group.

Rookus MA, van Leeuwen FE. Rookus MA, et al. Lancet. 1994 Sep 24;344(8926):844-51. doi: 10.1016/s0140-6736(94)92826-6. Lancet. 1994. PMID: 7916400

7

p53 protein overexpression in relation to risk factors for breast cancer.

van der Kooy K, Rookus MA, Peterse HL, van Leeuwen FE. van der Kooy K, et al. Among authors: rookus ma. Am J Epidemiol. 1996 Nov 15;144(10):924-33. doi: 10.1093/oxfordjournals.aje.a008862. Am J Epidemiol. 1996. PMID: 8916503

8

Induced abortion and risk for breast cancer: reporting (recall) bias in a Dutch case-control study.

Rookus MA, van Leeuwen FE. Rookus MA, et al. J Natl Cancer Inst. 1996 Dec 4;88(23):1759-64. doi: 10.1093/jnci/88.23.1759. J Natl Cancer Inst. 1996. PMID: 8944006

9

[Last word on hormone replacement and breast cancer?].

Rookus MA, van Leeuwen FE, Hamerlynck JV. Rookus MA, et al. Ned Tijdschr Geneeskd. 1998 Jan 17;142(3):111-3. Ned Tijdschr Geneeskd. 1998. PMID: 9557006 Dutch.

10

Physical activity and breast cancer risk in women aged 20-54 years.

Verloop J, Rookus MA, van der Kooy K, van Leeuwen FE. Verloop J, et al. Among authors: rookus ma. J Natl Cancer Inst. 2000 Jan 19;92(2):128-35. doi: 10.1093/jnci/92.2.128. J Natl Cancer Inst. 2000. PMID: 10639514

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page